Paper36926456
Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51.
Buffa V and 5 others. ACS Pharmacol Transl Sci, 2023. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51. Papers, record 36926456. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926456
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7543369 | X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. | Cell | 1995 | https://conductscience.org/library/papers/7543369 | PubMed |
| 2 | 34872938 | FKBP51 in the Oval Bed Nucleus of the Stria Terminalis Regulates Anxiety-Like Behavior. | eNeuro | 2021 | https://conductscience.org/library/papers/34872938 | PubMed |
| 3 | 29203717 | Hsp90 and FKBP51: complex regulators of psychiatric diseases. | Philos Trans R Soc Lond B Biol Sci | 2018 | https://conductscience.org/library/papers/29203717 | PubMed |
| 4 | 36104438 | Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/36104438 | PubMed |
| 5 | 36396784 | FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder. | Neuropsychopharmacology | 2023 | https://conductscience.org/library/papers/36396784 | PubMed |
| 6 | 23707272 | Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure. | Pain | 2013 | https://conductscience.org/library/papers/23707272 | PubMed |
| 7 | 15565110 | Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. | Nat Genet | 2004 | https://conductscience.org/library/papers/15565110 | PubMed |
| 8 | 33666419 | Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. | J Med Chem | 2021 | https://conductscience.org/library/papers/33666419 | PubMed |
| 9 | 34298958 | Stress-Related Dysfunction of Adult Hippocampal Neurogenesis-An Attempt for Understanding Resilience? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298958 | PubMed |
| 10 | 29575542 | The stressed brain of humans and rodents. | Acta Physiol (Oxf) | 2018 | https://conductscience.org/library/papers/29575542 | PubMed |
| 11 | 36217203 | SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/36217203 | PubMed |
| 12 | 29573791 | Understanding the Molecular Mechanisms Underpinning Gene by Environment Interactions in Psychiatric Disorders: The FKBP5 Model. | Biol Psychiatry | 2018 | https://conductscience.org/library/papers/29573791 | PubMed |
| 13 | 35296422 | Duration of Reduction in Enduring Stress-Induced Hyperalgesia Via FKBP51 Inhibition Depends on Timing of Administration Relative to Traumatic Stress Exposure. | J Pain | 2022 | https://conductscience.org/library/papers/35296422 | PubMed |
| 14 | 25286062 | Stereoselective construction of the 5-hydroxy diazabicyclo[4.3.1]decane-2-one scaffold, a privileged motif for FK506-binding proteins. | Org Lett | 2014 | https://conductscience.org/library/papers/25286062 | PubMed |
| 15 | 26954324 | Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51. | J Med Chem | 2016 | https://conductscience.org/library/papers/26954324 | PubMed |
| 16 | 8662507 | Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. | Science | 1996 | https://conductscience.org/library/papers/8662507 | PubMed |
| 17 | 30963102 | The Disease-Associated Chaperone FKBP51 Impairs Cognitive Function by Accelerating AMPA Receptor Recycling. | eNeuro | 2019 | https://conductscience.org/library/papers/30963102 | PubMed |
| 18 | 19418507 | Fluorescent probes to characterise FK506-binding proteins. | Chembiochem | 2009 | https://conductscience.org/library/papers/19418507 | PubMed |
| 19 | 28978117 | A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma. | Oncotarget | 2017 | https://conductscience.org/library/papers/28978117 | PubMed |
| 20 | 32755820 | Stress, glucocorticoid signaling pathway, and metabolic disorders. | Diabetes Metab Syndr | 2020 | https://conductscience.org/library/papers/32755820 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42902147 | Targeting neuronal FKBP5 attenuates mechanical allodynia by suppressing NF-κB-mediated neuroinflammation in an NTG-induced chronic migraine mouse model. | J Headache Pain | 2026 | https://conductscience.org/library/papers/42902147 | PubMed |
| 42536755 | Corticosterone-linked microglial activity underpins sexually dimorphic neuroplasticity after ketamine anesthesia. | Sci Adv | 2026 | https://conductscience.org/library/papers/42536755 | PubMed |
| 42171632 | Inhibition of FKBP51 alleviates depressive-like behaviors via AKT/mTOR-dependent autophagy and synaptic plasticity. | Int J Neuropsychopharmacol | 2026 | https://conductscience.org/library/papers/42171632 | PubMed |
| 41668209 | FKBP5 regulates interferon signaling leading to myeloid cell activation in multiple sclerosis. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/41668209 | PubMed |
| 41166420 | Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41166420 | PubMed |
| 40269902 | Xiao Yao San mitigates corticosterone stimulation-induced hippocampal neuronal damage by inhibiting GR phosphorylation and nuclear translocation via FKBP4 involvement. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/40269902 | PubMed |
| 40254776 | FKBP5 Induces Senescence in BMSCs and Inhibits Osteogenic Differentiation Through the Canonical WNT/β-Catenin Signalling Pathway in Senile Osteoporosis. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40254776 | PubMed |
| 40096182 | In silico identification of novel ligands targeting stress-related human FKBP5 protein in mental disorders. | PLoS One | 2025 | https://conductscience.org/library/papers/40096182 | PubMed |
| 38786025 | The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, Cancer, and Type 2 Diabetes Mellitus. | Cells | 2024 | https://conductscience.org/library/papers/38786025 | PubMed |
| 37355700 | SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators. | J Neuroinflammation | 2023 | https://conductscience.org/library/papers/37355700 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36926456
GET https://conductscience.org/api/papers/v1/36926456/references?page=2